What Azoospermia Is and Typical Symptoms
Azoospermia is a reproductive condition defined as the complete absence of spermatozoa in the ejaculate after centrifugation. It is diagnosed in roughly one per cent of all men and up to fifteen per cent of men seeking fertility care. Ejaculate appearance, volume, and sexual function are generally typical, so the condition is usually discovered only during fertility investigations when a couple cannot conceive after a year of unprotected intercourse.
Clinically, azoospermia falls into two primary forms:
- Obstructive Azoospermia (OA): The testicles produce sperm normally, but physical blockages or absent ducts prevent sperm from exiting. Causes include prior vasectomy, surgical trauma, infection, or congenital bilateral absence of the vas deferens (CBAVD).
- Non-Obstructive Azoospermia (NOA): The reproductive tract is patent, but the testicles produce very few or no mature sperm. Contributing factors include primary testicular failure, undescended testicles, previous chemotherapy, or genetic variations such as Klinefelter syndrome and Y-chromosome microdeletions.
Most men have no overt discomfort. Occasional hormonal imbalances can cause reduced facial hair, low libido, or gynaecomastia, which are evaluated during Urology consultations.
How Azoospermia Is Diagnosed
Differentiating between obstructive and non-obstructive forms is critical before determining a care plan.
Essential Diagnostic Investigations
Clinics perform targeted assessments through Check-ups & Diagnostics services:
- Repeat Semen Analysis: At least two semen analyses, taken after two to seven days of abstinence, must verify the absence of sperm. Centrifugation of the ejaculate at 3000g for fifteen minutes is essential to examine the pellet thoroughly, confirming the complete absence of viable sperm and distinguishing azoospermia from cryptozoospermia.
- Hormonal Profiling: Blood tests for follicle-stimulating hormone (FSH), luteinising hormone (LH), and testosterone evaluate testicular health through Endocrinology testing. Elevated FSH often indicates primary testicular failure.
- Genetic Testing: Karyotyping assesses chromosomal structure, while Y-chromosome microdeletion panels screen the AZF regions. CFTR gene analysis is performed if ductal structures are absent.
- Ultrasound Imaging: Scrotal ultrasound checks testicular volume and vascular structures. Transrectal ultrasound specifically looks for ejaculatory duct cysts, calcifications, or dilated seminal vesicles that point towards correctable obstructive causes.
Medical Records to Bring
Patients should bring prior semen analyses, hormone tests, surgical notes, and genetic reports. Having existing records prevents repeated testing and streamlines your initial clinical assessment.
Treatment Options and Clinical Approaches
Interventions depend directly on whether the condition is obstructive or non-obstructive. Your specialist will evaluate your test results to recommend an appropriate strategy.
| Option |
Typically used when |
Things to know |
| Microsurgical Reconstruction |
Physical blockage exists after vasectomy or epididymal injury. |
Procedures like vasovasostomy restore natural sperm flow when ductal quality permits. |
| Epididymal Aspiration (PESA / MESA) |
Obstructive cases where reconstruction is unsuitable. |
Collects sperm directly from the epididymis using fine-needle or microsurgical methods. |
| Microscopic Testicular Sperm Extraction (micro-TESE) |
Non-obstructive azoospermia with impaired sperm production. |
Uses an operating microscope to identify promising seminiferous tubules while preserving testicular tissue. |
| Hormone Stimulation Therapy |
Secondary hypogonadism with deficient pituitary signalling. |
Injections stimulate the testicles to initiate sperm production over several months. |
Retrieved sperm are paired with intracytoplasmic sperm injection (ICSI) as part of an IVF & Fertility protocol. Realistic expectations are essential: micro-TESE retrieves viable sperm in approximately 40% to 50% of non-obstructive cases, and individual outcomes cannot be assured in advance.
Planning Your Treatment in Turkey
Undergoing treatment in Turkey requires careful scheduling between the patient, their partner, and the clinic.
The process starts with a preliminary review of your medical records. The urologist examines hormone profiles and genetic panels to evaluate whether surgical retrieval is viable. Once travel is arranged, patients typically stay in Turkey for 5 to 10 days. This period covers pre-operative assessments, anaesthesia clearance, the procedure, and immediate post-operative recovery. Surgical retrieval procedures like micro-TESE are performed under general or regional anaesthesia in accredited operating theatres, prioritising patient comfort and surgical precision.
If combining sperm retrieval with your partner's egg collection, cycles are synchronised under the guidance of Gynaecology teams. Alternatively, retrieved sperm can be cryopreserved first. Before returning home, you will receive wound care instructions and a comprehensive medical summary for your local doctor to support your ongoing recovery.
When Travel Is Not Advisable and Emergency Signs
Azoospermia care is elective. You should delay travel and seek urgent local medical attention if you experience:
- Acute, severe scrotal pain or swelling, which may indicate testicular torsion or epididymo-orchitis.
- Active genital infections with fever or urethral discharge.
- Unmanaged cardiovascular or respiratory disorders that raise anaesthesia risks.
- A palpable, hard testicular lump, requiring urgent local evaluation.
All treatment decisions are determined by the treating physician after in-person clinical examination and review of your diagnostic findings.
